Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2024 | Update on the PIMMs trial of ivosidenib for patients with IDH1-mutated CCUS

Kelly Bolton • 1 Jun 2024
ASCO 2024
General Ivosidenib
PIMMs

Kelly Bolton, MD, PhD, Washington University School of Medicine, St. Louis, MO, provides a brief update on the PIMMs study (NCT05030441) investigating ivosidenib in patients with IDH1-mutated clonal cytopenia of undetermined significance (CCUS). This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kelly Bolton

Germline predisposition to clonal hematopoiesis and its role in leukemia progression
1:39
Germline predisposition to clonal hematopoiesis and its role in leukemia progression
Kelly Bolton • 1 Jun 2024
CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for hematologists
CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for hematologists
Eric Padron et al. • 25 Mar 2024
The link between clonal hematopoiesis and COVID-19
9:25
The link between clonal hematopoiesis and COVID-19
Kelly Bolton • 10 Sep 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals